#Huntingdon_Valley
Menarini Silicon Biosystems Unveils PACE Trial Findings on CTC Enumeration for Breast Cancer Treatment#United_States#Breast_Cancer#Menarini#CTC#Huntingdon_Valley
Menarini Silicon Biosystems Unveils PACE Trial Findings on CTC Enumeration for Breast Cancer Treatment
Menarini Silicon Biosystems has revealed insights from the PACE trial on counting circulating tumor cells (CTC) in metastatic breast cancer to guide treatment strategies.
third-news.com
December 22, 2025 at 8:09 AM
Menarini Silicon Biosystems Reports PACE Trial Findings for CTC Enumeration in Metastatic Breast Cancer#USA#Menarini#Huntingdon_Valley#CELLSEARCH#CTC_enumeration
Menarini Silicon Biosystems Reports PACE Trial Findings for CTC Enumeration in Metastatic Breast Cancer
Menarini Silicon Biosystems announces results from the PACE trial, showcasing how CELLSEARCH® CTC enumeration aids treatment decisions for a specific subtype of breast cancer.
third-news.com
December 22, 2025 at 8:06 AM
SRN Advisors, LLC Updates Siren Nasdaq NexGen Economy ETF Strategy and Name#USA#NASDAQ#SRN_Advisors#Huntingdon_Valley#Siren_ETF
SRN Advisors, LLC Updates Siren Nasdaq NexGen Economy ETF Strategy and Name
SRN Advisors, LLC announces significant changes to the Siren Nasdaq NexGen Economy ETF, focusing on a new investment strategy and name as of December 29, 2025.
third-news.com
December 19, 2025 at 3:23 PM
Siren DIVCON Dividend Defender ETF Transitions to Leaders ETF: A Strategic Move by SRN Advisors#USA#Siren_ETF#Dividend_Defender#DIVCON_Leaders#Huntingdon_Valley,_PA
Siren DIVCON Dividend Defender ETF Transitions to Leaders ETF: A Strategic Move by SRN Advisors
SRN Advisors announces the reorganization of the Siren DIVCON Dividend Defender ETF into the Siren DIVCON Leaders Dividend ETF, streamlining operations.
third-news.com
December 8, 2025 at 8:37 PM